Telix Pharmaceuticals Limited Stock Nasdaq
Stocks
TLX
US87961M1053
Biotechnology & Medical Research
OTC Markets Traded|
Real-time Estimate
Cboe BZX
18:40:55 29/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 9.565 USD | +3.29% |
|
+0.21% | +27.64% |
| Market Cap | 4.44B 3.12B 2.8B 2.59B 2.35B 4.38B 298B 30.98B 12.34B 156B 11.72B 11.48B 494B | P/E 2026 * |
196x | P/E 2027 * | 2,324x |
|---|---|---|---|---|---|
| Enterprise Value | 4.97B 3.5B 3.14B 2.9B 2.63B 4.91B 333B 34.67B 13.81B 174B 13.12B 12.84B 553B | EV / Sales 2026 * |
3.57x | EV / Sales 2027 * | 3.13x |
| Free-Float |
84.31% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| TLX | Delayed | |
CBOE
| TLX | Real-time | |
|
Deutsche Boerse AG
| Delayed | ||
|
Deutsche Boerse AG
| T3X0 | End-of-day quote |
Last Transcript: Telix Pharmaceuticals Limited
| 1 day | +3.29% | ||
| 1 week | +0.21% | ||
| Current month | -12.85% | ||
| 1 month | -15.70% | ||
| 3 months | -5.35% | ||
| 6 months | -8.34% | ||
| Current year | +27.64% |
| 1 week | 8.91 |  | 9.56 |
| 1 month | 8.91 | | 11.38 |
| Current year | 6.28 | | 13.11 |
| 1 year | 6.28 | | 13.11 |
| 3 years | 6.28 | | 30.36 |
| 5 years | 6.28 | | 30.36 |
| 10 years | 6.28 | | 30.36 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 51 | 03/01/2017 | |
Darren Smith
DFI | Director of Finance/CFO | 61 | 31/07/2022 |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 51 | 03/01/2017 | |
Mark Nelson
CHM | Chairman | 66 | 03/02/2026 |
Jann Skinner
BRD | Director/Board Member | 68 | 19/06/2018 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.29% | +0.21% | - | - | 3.12B | |
| +0.34% | -3.03% | +37.45% | +61.06% | 64.14B | |
| +1.21% | +2.91% | +12.50% | +84.32% | 55.53B | |
| +1.32% | +1.72% | +12.98% | +105.14% | 53.03B | |
| -0.35% | -0.28% | +27.41% | +56.66% | 45.99B | |
| -0.15% | -2.07% | +18.90% | +100.61% | 42.45B | |
| +1.19% | +1.73% | +229.08% | +940.52% | 40.45B | |
| -0.26% | -4.20% | +10.86% | +45.18% | 32.25B | |
| -1.19% | +44.57% | +106.40% | +92.72% | 34.47B | |
| -2.72% | -8.79% | +22.58% | -5.63% | 24.23B | |
| Average | +0.27% | +3.82% | +53.13% | +164.51% | 43.62B | |
| Weighted average by Cap. | +0.21% | +3.13% | +50.13% | +162.05% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.39B 979M 879M 812M 736M 1.37B 93.28B 9.71B 3.87B 48.81B 3.68B 3.6B 155B | 1.57B 1.11B 994M 919M 832M 1.55B 105B 10.98B 4.38B 55.2B 4.16B 4.07B 175B |
| Net income | 27.02M 19.02M 17.07M 15.78M 14.29M 26.7M 1.81B 189M 75.15M 948M 71.39M 69.88M 3.01B | 2.51M 1.76M 1.58M 1.46M 1.33M 2.48M 168M 17.5M 6.97M 87.95M 6.62M 6.48M 279M |
| Net Debt | 529M 372M 334M 309M 280M 522M 35.45B 3.69B 1.47B 18.55B 1.4B 1.37B 58.88B | 490M 345M 309M 286M 259M 484M 32.84B 3.42B 1.36B 17.18B 1.29B 1.27B 54.55B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/10/26 | $9.560 | +3.24% | 76,086 |
| 28/10/26 | $9.260 | +2.55% | 244,616 |
| 27/10/26 | $9.030 | +0.44% | 224,848 |
| 26/10/26 | $8.990 | -1.75% | 323,417 |
| 23/10/26 | $9.150 | -4.09% | 413,441 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TLX Stock
- TLX Stock
Select your edition
All financial news and data tailored to specific country editions
